Zydus settles patent case over Aptalis’ drug Canasa EP News Bureau Aug 14, 2017 Canasa is indicated to treat mildly to moderately active ulcerative colitis
Zydus to tie up with US-based research centre EP News Bureau May 1, 2015 To develop a vaccine against visceral leishmaniasis
Zydus to tie up with US-based research centre to develop vaccine Usha Sharma Apr 23, 2015 Etna Biotech will also donate $2,40,000 for advancing research under the NIH leishmaniasis programme
